News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Garland Jonathan Todd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 760 shares
@ $8.46, valued at
$6.4k
Paid exercise price by delivering 1,076 shares
@ $8.46, valued at
$9.1k
Exercised 1,951 restricted stock units
@ $0
Exercised 2,761 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,040 shares
@ $6.69, valued at
$20.3k
Paid exercise price by delivering 717 shares
@ $6.69, valued at
$4.8k
Exercised 7,804 restricted stock units
@ $0
Exercised 1,840 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 66,773 options to buy
@ $10.61, valued at
$708.5k
Granted 44,180 restricted stock units
@ $0 |
|
| 04/27/2022 |
4
| Garland Jonathan Todd (Chief Commercial Officer) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Granted 46,971 options to buy
@ $9.61, valued at
$451.4k
Granted 31,217 restricted stock units
@ $0 |
|
|
|